Evolus Strategic Advantage and Growth
LOVVOLUS
De
MARKET EXPANSION OPPORTUNITY: EXTRA STRENGTH JEUVEAU ®
EVOLUS IS UNIQUELY POSITIONED TO CAPITALIZE ON EXTRA STRENGTH JEUVEAUⓇ
ORIGINAL
JEUVEAU® 20U DOSE /
0.5ML CONCENTRATION
EXTRA STRENGTH
JEUVEAU 40U DOSE / 0.25ML
CONCENTRATION
Jeu 100
jeuve 100
euve 100
rabotulinumtoxinkJeuveau 100
Jeuveau
tulinumtoxin
100%
100
inumtoxinA.
Jeuveau
100
boulinumtoxinA-0
Jeuveau
tulinumtoxinA
leuveau
rabotulinumtoxinA.
Jeuveau
100
forinject
100
100克
100
STUDY DESIGN
100
100
e100
e100
Double-blind, single treatment, randomized,
controlled, prospective,
multi-center
Up to 1 year follow up | N=150
Three arms:
•
20U Botox Cosmetic
•
20U JeuveauⓇ
•
40U "Extra-Strength" JeuveauⓇ
Double dose, hyper-concentrated
FIRST PATIENT
ENROLLED
ENROLLMENT
COMPLETED
STUDY INITIATION
ACTIVITIES
2022
INTERIM RESULTS
PRESENTED
STUDY
COMPLETED
2023
RESULTS PRESENTED
23View entire presentation